XOMA Royalty (STU:X0M1) Short-Term Debt : €10.88 Mil (As of Dec. 2024)

View and export this data going back to 1986. Start your Free Trial

What is XOMA Royalty Short-Term Debt?

XOMA Royalty's Short-Term Debt for the quarter that ended in Dec. 2024 was €10.88 Mil.

XOMA Royalty's quarterly Short-Term Debt increased from Jun. 2024 (€5.31 Mil) to Sep. 2024 (€8.85 Mil) and increased from Sep. 2024 (€8.85 Mil) to Dec. 2024 (€10.88 Mil).

XOMA Royalty's annual Short-Term Debt increased from Dec. 2022 (€0.00 Mil) to Dec. 2023 (€5.08 Mil) and increased from Dec. 2023 (€5.08 Mil) to Dec. 2024 (€10.88 Mil).

XOMA Royalty Short-Term Debt Historical Data

The historical data trend for XOMA Royalty's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

XOMA Royalty Short-Term Debt Chart

XOMA Royalty Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Short-Term Debt

Get a 7-Day Free Trial

6.65

5.08

10.88

XOMA Royalty Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Short-Term Debt	Get a 7-Day Free Trial															5.08	5.65	5.31	8.85	10.88

XOMA Royalty Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

XOMA Royalty Short-Term Debt Related Terms

Thank you for viewing the detailed overview of XOMA Royalty's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

XOMA Royalty Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » XOMA Royalty Corp (STU:X0M1) » Definitions » Short-Term Debt

Comparable Companies

Traded in Other Exchanges

XOMAO.PFD:USA XOMAP.PFD:USA XOMA:USA 0M26:UK

Address

2200 Powell Street, Suite 310, Emeryville, CA, USA, 94608

Website

https://www.xoma.com

XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.

XOMA Royalty Headlines

No Headlines